Traitement en cours

Veuillez attendre...

Paramétrages

Paramétrages

Aller à Demande

1. WO1988004173 - PROCEDE ET COMPOSITION POUR LE TRAITEMENT DE L'OBESITE, DE LA DEPRESSION, DE L'ABUS DE MEDICAMENTS ET/OU DE DROGUES ET DE LA NARCOLEPSIE

Numéro de publication WO/1988/004173
Date de publication 16.06.1988
N° de la demande internationale PCT/US1987/003154
Date du dépôt international 02.12.1987
Demande présentée en vertu du Chapitre 2 06.09.1988
CIB
A61K 31/55 2006.01
ANÉCESSITÉS COURANTES DE LA VIE
61SCIENCES MÉDICALE OU VÉTÉRINAIRE; HYGIÈNE
KPRÉPARATIONS À USAGE MÉDICAL, DENTAIRE OU POUR LA TOILETTE
31Préparations médicinales contenant des ingrédients actifs organiques 
33Composés hétérocycliques
395ayant l'azote comme hétéro-atome d'un cycle, p.ex. guanéthidine ou rifamycines
55ayant des cycles à sept chaînons, p.ex. azélastine, pentylènetétrazole
CPC
A61K 31/55
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
55having seven-membered rings, e.g. azelastine, pentylenetetrazole
Y10S 424/15
YSECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
10TECHNICAL SUBJECTS COVERED BY FORMER USPC
STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
424Drug, bio-affecting and body treating compositions
15Suppositories
Y10S 514/81
YSECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
10TECHNICAL SUBJECTS COVERED BY FORMER USPC
STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
514Drug, bio-affecting and body treating compositions
81Addiction
Y10S 514/909
YSECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
10TECHNICAL SUBJECTS COVERED BY FORMER USPC
STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
514Drug, bio-affecting and body treating compositions
909Obesity
Y10S 514/953
YSECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
10TECHNICAL SUBJECTS COVERED BY FORMER USPC
STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
514Drug, bio-affecting and body treating compositions
953Shaped forms adapted for noningestible use other than suppository type, e.g. films, inserts
Y10S 514/966
YSECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
10TECHNICAL SUBJECTS COVERED BY FORMER USPC
STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
514Drug, bio-affecting and body treating compositions
966Rectal
Déposants
  • SEROTONIN INDUSTRIES OF CHARLESTON [US]/[US]
Inventeurs
  • HOHENWARTER, Mark, W.
Mandataires
  • FOX, Samuel, L. @
Données relatives à la priorité
938,30705.12.1986US
Langue de publication anglais (EN)
Langue de dépôt anglais (EN)
États désignés
Titre
(EN) METHOD AND COMPOSITION FOR TREATING OBESITY, DEPRESSION, DRUG ABUSE, AND NARCOLEPSY
(FR) PROCEDE ET COMPOSITION POUR LE TRAITEMENT DE L'OBESITE, DE LA DEPRESSION, DE L'ABUS DE MEDICAMENTS ET/OU DE DROGUES ET DE LA NARCOLEPSIE
Abrégé
(EN)
Compositions and methods for the treatment of obesity, depression, drug abuse, and narcolepsy. The compositions comprise a norepinephrine precursor such as L-tyrosine or L-phenylalanine in combination with a norepinephrine re-uptake inhibitor such as desipramine. In another embodiment of the invention, the compositions further comprise enzymatic cofactors for the biosynthesis of norepinephrine.
(FR)
Les compositions et les procédés décrits sont destinés au traitement de l'obésité, de la dépression, de l'abus de médicaments et/ou de drogues et de la narcolepsie. Lesdites compositions comprennent un précuseur de la norépinéphrine, telle que de la L-tyrosine ou de la L-phénylalanine, en combinaison avec un inhibiteur de la ré-ingestion de norépinéphrine, tel que de la désipramine. Dans n autre mode de réalisation de la présente invention, lesdites compositions comprennent également des cofacteurs enzymatiques pour la biosynthèse de la norépinéphrine.
Dernières données bibliographiques dont dispose le Bureau international